498 related articles for article (PubMed ID: 27094782)
21. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
22. Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia.
Lunzer MM; Yekkirala A; Hebbel RP; Portoghese PS
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6061-5. PubMed ID: 17389363
[TBL] [Abstract][Full Text] [Related]
23. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
Baamonde A; Menéndez L; González-Rodríguez S; Lastra A; Seitz V; Stein C; Machelska H
Sci Rep; 2020 Oct; 10(1):18599. PubMed ID: 33122720
[TBL] [Abstract][Full Text] [Related]
24. Involvement of peripheral mechanism in the verapamil-induced potentiation of morphine analgesia in mice.
Shimizu N; Kishioka S; Maeda T; Fukazawa Y; Dake Y; Yamamoto C; Ozaki M; Yamamoto H
J Pharmacol Sci; 2004 Aug; 95(4):452-7. PubMed ID: 15297768
[TBL] [Abstract][Full Text] [Related]
25. Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain.
Wu LX; Dong YP; Zhu QM; Zhang B; Ai BL; Yan T; Zhang GH; Sun L
BMC Cancer; 2021 Oct; 21(1):1128. PubMed ID: 34670518
[TBL] [Abstract][Full Text] [Related]
26. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.
Stein C; Pflüger M; Yassouridis A; Hoelzl J; Lehrberger K; Welte C; Hassan AH
J Clin Invest; 1996 Aug; 98(3):793-9. PubMed ID: 8698872
[TBL] [Abstract][Full Text] [Related]
27. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors.
Johnston IN; Westbrook RF
Behav Brain Res; 2004 May; 151(1-2):151-8. PubMed ID: 15084430
[TBL] [Abstract][Full Text] [Related]
29. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
30. Analgesic activity of a novel bivalent opioid peptide compared to morphine via different routes of administration.
Silbert BS; Lipkowski AW; Cepeda MS; Szyfelbein SK; Osgood PF; Carr DB
Agents Actions; 1991 Jul; 33(3-4):382-7. PubMed ID: 1950824
[TBL] [Abstract][Full Text] [Related]
31. Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
Abbruscato TJ; Williams SA; Misicka A; Lipkowski AW; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1996 Mar; 276(3):1049-57. PubMed ID: 8786534
[TBL] [Abstract][Full Text] [Related]
32. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists.
Sevostianova N; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Nov; 525(1-3):83-90. PubMed ID: 16297905
[TBL] [Abstract][Full Text] [Related]
33. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
34. Synergistic analgesic effects between neuronostatin and morphine at the supraspinal level.
Yang SB; Yang AM; Shao TJ; Su SF; Chen Q
Peptides; 2013 Jun; 44():105-10. PubMed ID: 23548325
[TBL] [Abstract][Full Text] [Related]
35. Spinal and peripheral mechanisms involved in the enhancement of morphine analgesia in acutely inflamed mice.
González-Rodríguez S; Hidalgo A; Baamonde A; Menéndez L
Cell Mol Neurobiol; 2010 Jan; 30(1):113-21. PubMed ID: 19655242
[TBL] [Abstract][Full Text] [Related]
36. Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors.
Komla E; Stevens DL; Zheng Y; Zhang Y; Dewey WL; Akbarali HI
J Pharmacol Exp Ther; 2019 Sep; 370(3):504-513. PubMed ID: 31248978
[TBL] [Abstract][Full Text] [Related]
37. The opioid peptide analogue biphalin induces less physical dependence than morphine.
Yamazaki M; Suzuki T; Narita M; Lipkowski AW
Life Sci; 2001 Jul; 69(9):1023-8. PubMed ID: 11508644
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
39. Lack of tolerance in peripheral opioid analgesia in mice.
Tokuyama S; Inoue M; Fuchigami T; Ueda H
Life Sci; 1998; 62(17-18):1677-81. PubMed ID: 9585156
[TBL] [Abstract][Full Text] [Related]
40. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
